InvestorsHub Logo
Followers 8
Posts 145
Boards Moderated 0
Alias Born 10/18/2023

Re: falconer66a post# 454339

Monday, 03/18/2024 1:34:25 PM

Monday, March 18, 2024 1:34:25 PM

Post# of 458805
I think you mean well, Falconer, but you really ought to tone down the "sure thing" attitude that Anavex's future trials would be approved.

You were incorrect about Rett, basically saying it was a sure thing, when others here posted their concerns about the trial being underpowered and the risk of a stronger-than-expected placebo response. At this point we don't even know if Rett is still a priority for Anavex. It sure doesn't seem like it given the relative silence over the last few months and the immediate pivot to A371 instead.

I enjoy your posts for what they are -- mere opinion. Your positivity may comfort those who need it, but the reality is neither you nor I nor anyone else has any idea whether the drug works "strongly."

You say there should be no haziness and that's correct, but this is Anavex. Everything this management team does is clouded in haziness, often unnecessarily.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News